These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34931476)

  • 1. Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient.
    Okano Y; Kunishige M; Kondo Y; Kadota N; Morishita A; Naruse K; Machida H; Hatakeyama N; Hino H; Shinohara T; Sakiyama S; Takeuchi E
    Thorac Cancer; 2022 Feb; 13(3):510-513. PubMed ID: 34931476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.
    Zhang F; Xu Y; Guo S; Li S; Ma K; Wang J; Wei S
    Ann Palliat Med; 2022 Sep; 11(9):3020-3027. PubMed ID: 36217630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Advanced Lung Squamous Cell Carcinoma with Idiopathic Pulmonary Fibrosis Treated with Salvage Surgery and Chemotherapy Using Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel].
    Morio A
    Gan To Kagaku Ryoho; 2018 Aug; 45(8):1193-1196. PubMed ID: 30158418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.
    Shiroyama T; Tamiya M; Minami S; Takata S; Masuhiro K; Futami-Nishijima Y; Uenami T; Mori M; Koba T; Matsuki T; Takimoto T; Suzuki H; Okamoto N; Komuta K; Hirashima T; Kumanogoh A; Kijima T
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):461-467. PubMed ID: 28688052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
    Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S
    Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
    Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
    J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Squamous Cell Lung Cancer in an Elderly Patient with Low PD-L1 Expression Effectively Treated with Nab-Paclitaxel(Nab-PTX)plus Carboplatin (CBDCA)plus Pembrolizumab for a Recurrence after Operation].
    Sakaguchi K; Kosaka M; Yamazaki Y
    Gan To Kagaku Ryoho; 2020 May; 47(5):819-821. PubMed ID: 32408327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of complete resection of non-squamous non-small-cell lung cancer after induction chemotherapy using carboplatin, paclitaxel, and bevacizumab].
    Kawaharada Y; Imai K; Minamiya Y; Saito H; Konno H; Fujishima S; Ogawa J
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1533-7. PubMed ID: 23064066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
    Spigel DR; Jotte RM; Aix SP; Gressot L; Morgensztern D; McCleod M; Socinski MA; Daniel D; Juan-Vidal O; Mileham KF; West H; Page R; Reinmuth N; Knoble J; Chen T; Bhore R; Wolfsteiner M; Ong TJ; Gridelli C; Thomas M;
    Clin Lung Cancer; 2021 Jan; 22(1):6-15.e4. PubMed ID: 33097414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA)plus Nab-Paclitaxel(Nab-PTX)].
    Yoshino Y; Miyagi J; Toume R; Naha Y; Uchihara T; Akamine M; Nakazato H; Kawakami M; Tomori T; Nagayoshi S; Nagamine S; Tomiyama T; Ohmine Y; Sasaki H; Ishikawa M; Maeshiro K
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1171-1173. PubMed ID: 31296824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer.
    Morimoto K; Yamada T; Yokoi T; Kijima T; Goto Y; Nakao A; Hibino M; Takeda T; Yamaguchi H; Takumi C; Takeshita M; Chihara Y; Yamada T; Hiranuma O; Morimoto Y; Iwasaku M; Kaneko Y; Uchino J; Takayama K
    Lung Cancer; 2021 Nov; 161():26-33. PubMed ID: 34500218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic response to pembrolizumab with chemotherapy followed by salvage surgery in a lung cancer patient.
    Saito S; Toyokawa G; Momosaki S; Kozuma Y; Shoji F; Yamazaki K; Takeo S
    Thorac Cancer; 2021 Aug; 12(15):2217-2220. PubMed ID: 34151529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
    Akiyama N; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Uto T; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Suda T
    Invest New Drugs; 2019 Jun; 37(3):531-537. PubMed ID: 30790149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of advanced pulmonary squamous cell carcinoma cured by resection through preoperative induction of immune checkpoint inhibitor.
    Kawai H; Saito Y; Demura R; Odaka H; Takahashi S; Takahashi K; Kurokawa H; Enomoto K
    Thorac Cancer; 2018 Apr; 9(4):495-497. PubMed ID: 29418077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
    Borghaei H; Langer CJ; Paz-Ares L; Rodríguez-Abreu D; Halmos B; Garassino MC; Houghton B; Kurata T; Cheng Y; Lin J; Pietanza MC; Piperdi B; Gadgeel SM
    Cancer; 2020 Nov; 126(22):4867-4877. PubMed ID: 32914866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
    Paz-Ares L; Luft A; Vicente D; Tafreshi A; Gümüş M; Mazières J; Hermes B; Çay Şenler F; Csőszi T; Fülöp A; Rodríguez-Cid J; Wilson J; Sugawara S; Kato T; Lee KH; Cheng Y; Novello S; Halmos B; Li X; Lubiniecki GM; Piperdi B; Kowalski DM;
    N Engl J Med; 2018 Nov; 379(21):2040-2051. PubMed ID: 30280635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).
    Miyanaga A; Asahina H; Watanabe S; Shukuya T; Tsubata Y; Hosomi Y; Sugawara S; Maemondo M; Okano T; Morita S; Matsuyama K; Kobayashi K; Seike M
    Clin Lung Cancer; 2023 Jun; 24(4):371-375. PubMed ID: 36849264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
    Umezu H; Chida M; Inoue T; Araki O; Tamura M; Tatewaki M; Fukushima Y; Honma K
    Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):434-7. PubMed ID: 20703868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
    Gadgeel SM; Stevenson JP; Langer CJ; Gandhi L; Borghaei H; Patnaik A; Villaruz LC; Gubens M; Hauke R; Yang JC; Sequist LV; Bachman R; Saraf S; Raftopoulos H; Papadimitrakopoulou V
    Lung Cancer; 2018 Nov; 125():273-281. PubMed ID: 30429032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102.
    Yokoi T; Minami S; Shiroyama T; Koba T; Torii Y; Sugimoto H; Niki M; Mori M; Morimura O; Hirashima T; Komuta K; Kijima T
    Intern Med; 2019 May; 58(10):1405-1410. PubMed ID: 30713297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.